Heart catheters do not benefit patientsNovember 03, 2006Doctors should probably stop using pulmonary artery catheters because they do not benefit patients, say doctors from Australia in this week's BMJ. The pulmonary artery catheter was invented in 1968. It enabled bedside monitoring in critically ill patients by measuring heart output and capillary pressure in the lungs and became widely used in intensive care units. But reports of serious complications soon appeared and arguments for and against its use have continued ever since. The most recent evaluation, commissioned by the NHS Health Technology Assessment (HTA) programme, found that pulmonary artery catheters do not benefit patients and concluded that withdrawing them from UK intensive care units would be cost effective. Another recent trial in patients with acute lung injury confirmed these findings, while an analysis of 13 trials reported no overall effect of using these devices on mortality or length of hospital stay. So what should clinicians do with all this information? Given that the use of pulmonary artery catheters increases the risk of important complications, continued use of these devices is difficult to defend, say the authors. The onus is now on the proponents of the pulmonary artery catheter and related devices to limit their use to clinical trials and to show that protocols based on such devices do benefit patients, they conclude. Heart catheters |
|||||||||||||
| Related Pulmonary Artery Catheter Current Events and Pulmonary Artery Catheter News Articles Use of pulmonary artery catheter decreases substantially in US Use of the pulmonary artery catheter decreased by 65 percent in the U.S. between 1993 and 2004, possibly due to growing evidence that this invasive procedure does not reduce the risk of death for hospitalized patients. For patients with severe lung injury, less is more Results from the largest controlled clinical trial of fluid management methods in patients with severe lung injury provide important new information on the risks and benefits of patient care strategies currently used in the intensive care unit. Steroids do not prolong survival in intensive care patients with ARDS on life support Corticosteroids do not improve survival in patients with late-stage acute respiratory distress syndrome (ARDS), according to new results from the ARDS Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. Pulmonary artery catheter use neutral for patient outcomes The use of a pulmonary artery catheter (PAC) - a device used for more than 30 years to assess cardiovascular health and to help guide the treatment of critically ill patients - does not appear to improve outcomes nor confer added risks to patients. Blood flow monitoring system to reduce risks during heart surgery A unique haemodynamic (blood flow) monitoring system which will help to minimise the risk of complications during cardiovascular surgery is being developed by Leeds-based medical devices company, Medics Research Ltd. More Pulmonary Artery Catheter Current Events and Pulmonary Artery Catheter News Articles |
|||||||||||||
|
|||||||||||||
|
|||||||||||||